You need to enable JavaScript to run this app.
☰
×
About
Methodology
The Team
News
Conference
Contact Us
About
Methodology
The Team
News
Conference
Contact Us
Adult ADHD
Adult ADHD
Diagnosis
Medication
Recommendation
Does patient have comorbid psychiatric disorder(s)?
None
Depressive Symptoms
Anxiety
Psychosis
Substance Use Disorder
Family history of sudden cardiac death
X
Remote
Active
< 30% improvement after
adequate dose titration
Yes
Adequate response
(> 30% improvement)
No
< 30% improvement after
adequate dose titration
< 30% improvement after
adequate dose titration
Adequate response
(> 30% improvement)
Adequate response
(> 30% improvement)
Adult ADHD
Check prescription drug
monitoring database
Failed stimulant in past
or responded previously
to non-stimulant
Consider CBT in
combination with
pharmacotherapy at
any point during
treatment
SOR A
Medical
Comorbidities
Medical
If history of cardiac
arrhythmias or family
history of sudden
cardiac death, consult
cardiology
Substance use
Use non-stimulant or
long-acting stimulant
cautiously; consider
Vyvanse
Other
substances
Weigh risks
and benefits
of stimulants
Amphetamine
or Cocaine
Avoid stimulants
Psychiatric
Comorbidities
Psychosis:
treat psychosis;
avoid stimulants
Depressive or
anxious
symptoms
Independent of ADHD &
its psychosocial
consequences
See corresponding decision
support tool and treat both
disorders concurrently
Consider bupropion for the
treatment of MDD (only
without comorbid anxiety)
SOR A
Secondary to
ADHD & its
psychosocial
consequences
Treat ADHD and
re-evaluate
depressive or
anxiety symptoms
First choice: Stimulants
(
SOR A
)
Amphetamines*
Methylphenidates
(Consider long-acting over
short/intermediate acting
based on diversion and misuse potential
of short acting agents)
Try another
first-line treatment
(Consider trying alternate stimulant class)
Second choice:
Atomoxetine
SOR A
Consider Bupropion
(third line; not FDA
approved)
*All things taken equally, consider amphetamine as first
choice in adults, based on meta-analysis data. Lancet
Psychiatry. 2018 Sep 5(9):727-738.
Maintain effective dose;
adjust as needed to
meet life needs